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ABSTRACT
DNA interstrand crosslinks (ICLs) are highly
cytotoxic lesions formed by a variety of important
anti-tumor agents. Despite the clinical importance of
ICLs, the mechanisms by which these lesions are
repaired in mammalian cells have so far remained
elusive. One of the obstacles in the study of ICL
repair has been the limited availability of suitable
methods for the synthesis of defined site-specific
ICLs. We report here the synthesis of a site-specific
ICL containing an ethylene-bridged G-T base pair
based on the incorporation of a crosslink precursor
containing a selectively reactive group on one strand
using solid-phase synthesis. 3-(2-chloroethyl)-
thymidine was incorporated into oligonucleotides
and underwent ICL formation upon annealing to a
complementary strand by reacting with the base
opposite to the modified T residue. A strong prefer-
ence for ICL formation with a G residue opposite the
reactive T was observed. Detailed characterization of
the reaction product revealed that the alkylation
reaction occurred with the O-6 group of G and a
mechanism accounting for this preference is pro-
posed. These G-T crosslinks introduced here will be
useful for studies of ICL repair.
INTRODUCTION
DNA interstrand crosslinks (ICLs) are among the most cyto-
toxic lesions known and are produced as a result of a reaction
of cellular DNA with compounds containing bifunctional
electrophilic moieties. The extraordinary cytotoxicity of
ICLs is due to the fact that they block all cellular processes
that involve the separation of dsDNA such as transcription
or replication (1). ICL-forming bifunctional compounds are
frequently used in cancer chemotherapy, but are also gener-
ated endogenously as metabolic side products (2). To coun-
teract the threats of ICLs, cells have developed mechanisms
to repair these lesions, and the failure to repair such lesions
is associated with inherited disorders such as Fanconi Anemia
(3,4). In contrast, the repair of ICLs in tumor cells leads to
resistance against anti-tumor agents (5,6). The understanding
of the mechanisms of ICL repair should, therefore, not only
signiﬁcantly contribute to our understanding of the molecular
basis of human disease, but also to the mechanisms of resist-
ance of tumor cells to chemotherapeutic agents. This know-
ledge should thus eventually facilitate the development of
new targets for cancer therapy. Although signiﬁcant progress
has been made in studying various DNA repair pathways
(7,8), the mechanisms underlying the repair of ICLs remain
poorly understood (1,2,5,9). Apart from the inherent com-
plexity of ICL repair, in which two damaged strands need
to be repaired, the difﬁculty of preparing well-deﬁned and
stable ICL-containing oligonucleotides as substrates for bio-
chemical and cell biological studies presents an additional
signiﬁcant hurdle in enabling the investigation of ICL repair
pathways. Traditionally ICLs have been prepared by treating
dsDNA with bifunctional alkylating agents, but this approach
offers little or no sequence speciﬁcity, produces complex
mixtures of mono adducts, intra- and interstrand crosslinks
and very low overall yield of the desired ICL (usually
<5%) (10–14).
De novo chemical synthesis provides an alternative for the
generation of site-speciﬁc ICLs. One approach has relied on
the cross-linking of mono nucleosides outside of DNA and
the incorporation of crosslinked dimers into DNA using
solid-phase synthesis after appropriate functionalization and
protection (15–20). This approach has been useful for the pre-
paration of deﬁned short oligonucleotides, but is somewhat
limited in scope due to the need of up to three different
protecting groups on the phosphoramidite of the dimer. A
practically more straightforward approach to the synthesis
of ICLs consists in the incorporation of crosslink precursor
in complementary single-stranded oligonucleotides and
installation of the crosslink using a suitable coupling reaction
after annealing of the two oligonucleotides. This approach
has been used with precursors in one (21–23) or both strands
of DNA (24–26).
As part of our program to study the repair of ICLs
formed by bifunctional alkylating agents used in cancer
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doi:10.1093/nar/gkl587chemotherapy, we were interested in developing synthetic
methods for the preparation of ICLs containing an ethylene
bridge between two Watson–Crick paired bases to mimic
the lesion formed by the chloro ethyl nitroso ureas
(CENUs) (14,27). We describe a new approach for the pre-
paration of ethylene bridge cross-linked DNA using a thym-
ine containing a chloroethyl group at the N-3 position in a
single-stranded oligonucleotide as a precursor. When paired
to a complementary oligonucleotide with the modiﬁed T
opposite to G, efﬁcient ICL formation was observed. Interest-
ingly, we found that of the two possible alkylation products
with N-1 or O-6 of guanine, only reaction with the O-6 posi-
tion was observed. Our studies thus provide a new approach
to the synthesis of deﬁned DNA interstrand crosslinks.
MATERIALS AND METHODS
All solvents and reagents were purchased from Sigma-
Aldrich. Anhydrous solvents were prepared by distillation
under an argon atmosphere in the presence of appropriate
drying agents. Flash chromatography was performed using
Silica gel 60 (220–430 mesh) as the adsorbent. Thin layer
chromatography (TLC) was performed using precoated TLC
plates (Merck, Silica gel 60 F254, 0.25 mm).
1H-NMR and
13C-NMR spectra were recorded on a Bruker
300 MHz NMR spectrometer operating at room temperature.
Chemical shifts are reported in parts per million (d) down-
ﬁeld from tetramethylsilane. Spin multiplicities are described
as s (singlet), bs (broad singlet), d (doublet), dd (doublet of
doublets), t (triplet) and m (multiplet). Mass spectra were
recorded by ESI-MS (Finnigan MAT TSQ-700) and oligo-
nucleotides were measured on Q-TOF Ultima Mass Spectro-
meter (Micromass, UK) with a nano-source in negative mode.
The spectra were obtained by deconvolution of the multiply
charged ions using the MaxEnt1 program (Micromass, UK).
HPLC was performed on a JASCO system equipped with a
BGB Analytic column: Nucleosil 100 s, C18, 5 mm 250 ·
4.0 mm
2. The C18-SepPak cartridges were obtained from
Micropore. Snake venom phosphodiesterase I (SVPD) was
purchased from Worthington Biochemical; calf intestine
phosphatase, from New England Biolabs.
N
3-(2-Chloroethyl-)-50-O-dimethoxytrityl-30-O-(tert-butyl-
dimethylsilyl)thymidine (2). At room temperature, Cs2CO3
(1.33 g, 4.09 mmol) was added to a solution of 50-O-
dimethoxytrityl-30-O-(tert-butyldimethylsilyl)thymidine 1 (28)
(899 mg, 1.36 mmol) in DMF (8 ml). The mixture was stirred
at room temperature for 20 min and then bromochloroethane
(338 ml, 4.09 mmol) was added. The reaction mixture was
stirred at room temperature for 17 h and treated with a satur-
ated solution of NH4Cl, extracted with ether, washed with
brine and H2O and dried over Na2SO4. Evaporation and silica
gel column chromatography (Hexane/EtOAc 5:1) gave 2
(850 mg, 86%) as a white foam. Rf (Hexane/EtOAc 3:1)
0.67;
1H NMR (300 MHz, (CD3)2SO): d 7.66 (d, 1H, J ¼
1.1 Hz), 7.41 (dd, 2H, J ¼ 7.2 Hz), 7.28 (m, 7H), 6.82 (d,
4H, J ¼ 8.77 Hz), 6.36 (t, 1H, J ¼ 6.26 Hz), 4.52 (m, 1H),
4.31 (dt, 2H, J ¼ 1.7, 6.9 Hz), 3.98 (dd, 1H, J ¼ 2.73, 5.85
Hz), 3.77 (s, 6H), 3.71 (t, 2H, J ¼ 6.8 Hz), 3.48 (dd, 1H, J ¼
2.76, 10.66 Hz), 3.20 (dd, 1H, J ¼ 2.85, 10.64 Hz), 2.34 (m,
1H), 2.20 (m, 1H), 1.52 (s, 3H), 0.84 (s, 9H), 0.03 (s, 3H),
0.00 (s, 3H);
13C NMR (75 MHz, (CD3)2SO): d 163.12,
158.65, 150.62, 144.13, 135.32, 133.90, 129.95, 128.04,
127.86, 127.01, 113.17, 109.99, 86.70, 86.69, 85.51, 71.94,
62.78, 55.11, 42.06, 41.51, 39.93, 25.60, 17.81, 12.50,
 0.47,  0.49; ESI MS (M + Na
+): 743.3 (calcd 742.99).
N
3-(2-Chloroethyl-)-50-O-dimethoxytritylthymidine (3). At
room temperature, tetrabutylammonium ﬂuoride (164 mg,
0.52 mmol) was added to a solution of N
3-(2-Chloroethyl-)-
50-O-dimethoxytrityl-30-O-(tert-butyldimethylsilyl)thymidine
2 (250 mg, 0.34 mmol) in THF (3 mL). The mixture was
stirred at room temperature for 1.5 h, treated with a saturated
solution of NH4Cl, extracted with EtOAc, washed with brine
and H2O and dried over Na2SO4. Evaporation and silica gel
column chromatography (hexane/EtOAc 3:1) gave 3 (188 mg,
89%) as a colorless oil. Rf (Hexane/EtOAc 3:1) 0.30;
1H
NMR (300 MHz, (CD3)2SO): d 7.58 (s, 1H), 7.41 (dd, 2H,
J ¼ 7.2 Hz), 7.33–7.23 (m, 7H), 6.88 (d, 4H, J ¼ 8.7 Hz),
6.24 (t, 1H, J ¼ 6.8 Hz), 5.33 (br s, OH), 4.33 (m, 1H),
4.13 (t, 2H, J ¼ 6.8 Hz), 3.90 (m, 1H), 3.73 (s, 6H), 3.71
(m, 2H), 3.21 (m, 2H), 2.32–2.15 (m, 2H), 1.52 (s, 3H);
13C NMR (75 MHz, (CD3)2SO): d 162.34, 158.14, 158.03,
150.12, 144.54, 135.29, 135.15, 134.57, 129.77, 129.59,
127.75, 127.54, 126.65, 113.23, 113.11, 108.56, 85.74,
85.51, 84.73, 70.22, 63.53, 54.91, 41.53, 40.20, 39.67,
12.68; ESI MS (M + Na
+): 629.1 (calcd 629.2).
N
3-(2-Chloroethyl-)-50-O-dimethoxytrityl-30-O-(2-Cyano-
ethyl-N,N-diisopropylphosphor-amidite) thymidine (4). At
room temperature, diisopropylethylamine (240 ml, 1.4
mmol) was added to a solution of N
3-(2-chloroethlyl-)-50-
O-dimethoxytritylthymidine 3 (322 mg, 0.53 mmol) in
CH2Cl2 (3 ml), followed by chloro(2-cyanoethoxy)(N,N-
diisopropylamino)phosphine (190 ml, 0.84 mmol). After
15 min, the reaction mixture was ﬁltered through a short
silica gel column (hexane/EtOAc 2:1), and fractions con-
taining the desired product were combined and evaporated
to dryness to afford 4 (mixture of diastereomers) as a
white foam (389 mg, 90%). Rf (Hexane/EtOAc 3:1) 0.55;
1H NMR (300 MHz, CDCl3): d 7.62 (s, 1/2H), 7.58 (s,
1/2H), 7.37 (d, 2H, J ¼ 8.8 Hz), 7.25 (m, 7H), 6.81 (d, 4H,
J ¼ 8.2 Hz), 6.39 (m, 1H), 4.63 (br. s, 1H), 4.27 (t, 2H, J ¼
6.68 Hz), 4.14 (d, 1H, J ¼ 12.17 Hz), 3.76 (s, 6H), 3.70 (m,
3H), 3.54 (m, 4H), 3.30 (m, 1H), 2.30–2.60 (m, 4H), 1.44 (s,
3H), 1.15 (s, 9H, J ¼ 5.9), 1.05 (d, 3H, J ¼ 6.4 Hz);
31P
NMR {
1H} (300 MHz, CDCl3): d 149.65, 149.16; ESI
MS (M
+): 806.5 (calcd 806.32).
N
3-(2-Iodoethyl-)-50-O-dimethoxytrityl-30-O-(tert-butyldi-
methylsilyl)thymidine (11) (20). At room temperature, NaI
(83 mg, 0.56 mmol) was added to a solution of N
3-
(2-chloroethyl-)-50-O-dimethoxytrityl-30-O-(tert-butyldi-
methylsilyl)thymidine 2 (213 mg, 0.29 mmol) in acetonitrile
(3 ml). The reaction mixture was heated at 70 C for 18 h,
cooled to room temperature, diluted with EtOAc, washed
with sodium thiosulfate (10%, 3 · 5 ml), dried over
Na2SO4 and evaporated to dryness to afford 11 (207 mg,
86%) as a light yellow foam. Rf (Hexane/EtOAc 3:1) 0.69.
Analytical data were in accordance with previous reports
for 11 (20).
1-{N
1-[30,50-O-(bis(tert-butyldimethylsilyl))-2-N-((dime-
thylamino)methylene)-20-deoxyguanosinyl]}-2-{N
3-[50-O-
(dimethoxytrityl)-30-O-(tert-butyldimethylsilyl)-thymidinyl]}
ethane (13). At room temperature, Ag2O (147 mg,
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3-(2-iodoethyl-)-
50-O-dimethoxytrityl-30-O-(tert-butyldimethylsilyl)thymidine
11 (346 mg, 0.42 mmol) and 30,50-O-(bis(tert-butyldimethyl-
silyl))-2-N-((dimethylamino)methylene)-20-deoxyguanosine
12 (228 mg, 0.42 mmol) in DMF (5 mL). The reaction
mixture was kept at room temperature for 48 h, treated
with a saturated solution of NH4Cl, extracted with ether,
washed with brine and H2O and dried over Na2SO4.E v a p o r a -
tion and silica gel column chromatography (CH2Cl2:MeOH
20:1) gave 13 (250 mg, 48%) as an oil. Rf (CH2Cl2/MeOH
10:1) 0.70;
1H NMR (300 MHz, (CD3)2SO): d 8.30 (br s,
1H), 7.98 (s, 1H), 7.49 (s, 1H), 7.40 (d, 2H, J ¼ 7.2 Hz),
7.35–7.20 (m, 7H), 6.89 (d, 4H, J ¼ 8.5 Hz), 6.23 (t, 1H,
J ¼ 6.8 Hz), 6.04 (t, 1H, J ¼ 6.5 Hz), 4.46 (m, 4H), 4.22
(m, 1H), 4.10 (m, 1H), 3.83 (m, 2H), 3.73 (s, 6H), 3.71
(dd, 1H, J ¼ 3.7, 9.8 Hz), 3.65 (dd, 1H, J ¼ 4.4, 10.9 Hz),
3.26 (d, 1H, J ¼ 6.5 Hz), 3.20 (dd, 1H, J ¼ 4.5, 10.9 Hz),
3.01 (s, 3H), 2.93 (s, 3H), 2.72 (m, 1H), 2.3–2.0 (m, 3H),
1.46 (s, 3H), 0.88 (s, 9H), 0.86 (s, 9H), 0.78 (s, 9H), 0.09
(s, 6H), 0.03 (s, 3H), 0.02 (s, 3H), 0.00 (s, 3H),  0.04
(s, 3H);
13C NMR (75 MHz, (CD3)2SO): d 162.54, 158.08,
157.17, 156.66, 150.22, 147.56, 144.37, 136.34, 135.12,
135.06, 133.62, 129.55, 127.73, 127.51, 126.69, 118.78,
113.08, 108.43, 86.85, 85.85, 85.22, 84.42, 82.14, 71.98,
71.26, 62.62, 54.91, 40.38, 39.81, 39.48, 39.09, 34.43, 25.59,
25.52, 25.43, 20.59, 17.80, 17.56, 17.41, 13.92, 12.37, -4.91;
ESI MS (M + Na
+): 1258.3 (calcd 1258.76).
1-[N
1-(20-deoxyguanosinyl)]-2-(N
3-thymidinyl)ethane (14).
At room temperature, tetrabutylammonium ﬂuoride (167mg,
0.53 mmol) was added to a solution of 1   {N
1-[30,50-O-
(bis(tert-butyldimethylsilyl))-2-N-((dimethylamino)methylene)-
20-deoxyguanosinyl]}-2-{N
3-[50-O-dimethoxytrityl-30-O-
(tert-butyldimethylsilyl)-thymidinyl]}ethane 13 (146 mg,
0.118 mmol) in THF (2 ml). After evaporation of the solvent
and silica gel column chromatography (CH2Cl2:MeOH 15:1)
the product was dissolved in MeOH (0.2 ml) and treated with
concentrated solution of NH4OH (200 ml). The reaction mix-
ture was heated at 55 C for 17 h, then the solvent was evap-
orated and the crude product was dissolved in MeOH (320 ml)
and water (80 ml) followed by acetic acid (1.6 ml). The reac-
tion mixture was left at room temperature for 30 min after
which the solvent was evaporated. The crude product was dis-
solved in H2O and washed with ethyl acetate (3 · 2 mL).
Evaporation of the water gave 14 (20 mg, 32%) as an oil.
Rf (CH2Cl2/MeOH 5:1) 0.13;
1H NMR (300 MHz,
(CD3)2SO): d 7.88 (s, 1H), 7.76 (s, 1H), 7.09 (br s, 2H),
6.12 (t, 1H, J ¼ 6.5 Hz), 6.08 (t, 1H, J ¼ 6.64 Hz), 5.24
(d, OH, J ¼ 3.8 Hz), 5.20 (d, OH, J ¼ 4.3 Hz), 5.03
(t, OH, J ¼ 5.2 Hz), 4.90 (t, OH, J ¼ 5.6 Hz), 4.33
(m, 1H), 4.22 (m, 2H), 4.15–4.04 (m, 3H), 3.78 (m, 2H),
3.62–3.49 (m, 4H), 2.49 (m, 1H), 2.20 (m, 1H), 2.1–2.0
(m, 2H), 1.75 (s, 3H);
13C NMR (75 MHz, (CD3)2SO): d
162.88, 156.47, 153.66, 150.41, 148.95, 135.18, 134.77,
115.53, 108.15, 87.40, 87.30, 84.84, 82.11, 70.61, 69.87,
61.66, 60.92, 39.62, 39.43, 38.38, 38.28, 12.72; ESI MS
(M + Na
+): 558.2 (calcd 558.5).
N
3-(2-Hydroxyethyl-)-50-O-dimethoxytrityl-30-O-(tert-butyl-
dimethylsilyl)thymidine (15). At room temperature, NaOH
(1M, 400 ml) was added to a solution of N
3-(2-iodoethyl-)-
50-O-dimethoxytrityl-30-O-(tert-butyldimethylsilyl)thymidine
11 (297 mg, 0.36 mmol) in THF (2 ml). The reaction mixture
was heated at 45 C for 17 h, cooled to room temperature,
treated with a saturated solution of NH4Cl, extracted with
EtOAc. The organic layer was washed with brine and H2O
and dried over Na2SO4. Evaporation and silica gel column
chromatography (hexane:EtOAc 2:1) gave 15 (180 mg,
71%) as a foam. Rf (Hexane/EtOAc 2:1) 0.38;
1HN M R
(300 MHz, (CD3)2SO): d 7.59 (d, 1H, J ¼ 1.1 Hz), 7.40
(dd, 2H, J ¼ 7.13 Hz), 7.34–7.22 (m, 7H), 6.90 (d, 4H,
J ¼ 8.57 Hz), 6.21 (t, 1H, J ¼ 6.4 Hz), 4.73 (t, OH, J ¼
5.8 Hz), 4.46 (m, 1H), 3.90 (d, 2H, J ¼ 6.2 Hz), 3.84 (dd,
1H, J ¼ 4.1, 7.2 Hz), 3.70 (s, 6H), 3.49 (dd, 2H, J ¼ 6.5,
12.4 Hz), 3.29 (dd, 1H, J ¼ 2.6, 10.6 Hz), 3.19 (dd, 1H,
J ¼ 4.3, 10.6 Hz), 2.32 (m, 1H), 2.18 (m, 1H), 1.55
(s, 3H), 0.79 (s, 9H), 0.01 (s, 3H), 0.00 (s, 3H);
13C NMR
(75 MHz, (CD3)2SO): d 162.75, 158.09, 150.23, 144.41,
135.18, 135.08, 134.11, 129.57, 127.72, 127.53, 126.69,
113.09, 108.53, 85.83, 85.14, 84.55, 71.22, 62.71, 57.29,
54.91, 42.48, 39.41, 25.43, 17.43, 12.38,  4.49; ESI MS
(M + Na
+): 725.4 (calcd 725.9).
1-{O
6-[30,50-O-(bis(tert-butyldimethylsilyl))-20-deoxyguano-
sinyl]}-2-{N
3-[50-O-(dimethoxytrityl)-30-O-(tert-butyldimethyl-
silyl)thymidinyl]}ethane (17).A t0  C, NaH (9.1 mg, 0.38
mmol) was added to a solution of N
3-(2-hydroxyethyl-)-50-
O-dimethoxytrityl-30-O-(tert-butyldimethylsilyl)-thymidine 15
(65 mg, 0.12 mmol) and 2-amino-6-chloro-9-[20-deoxy-3,5-
bis-O-(tert-butyldimethylsi1y1)-b-D-ribofuranosyl]purine 16
(29,30) (91 mg, 0.12 mmol) in DME. The reaction mixture
was left at room temperature for 1 h, treated with a saturated
solution of NH4Cl, extracted with EtOAc, washed with brine
and H2O and dried over Na2SO4. Evaporation and silica gel
column chromatography (hexane/EtOAc 3:1) gave 17
(110 mg, 74%) as a white foam. Rf (Hexane/EtOAc 1:1)
0.58;
1H NMR (500 MHz, (CD3)2SO): d 8.01 (s, 1H), 7.62
(s, 1H), 7.38 (d, 2H, J ¼ 7.4 Hz), 7.32–7.21 (m, 7H), 6.89
(d, 4H, J ¼ 8.5 Hz), 6.34 (br s, 2H), 6.19 (t, 1H, J ¼ 6.7
Hz), 6.14 (t, 1H, J ¼ 6.5 Hz), 4.60 (t, 2H, J ¼ 5.7 Hz),
4.50 (m, 1H), 4.45 (m, 1H), 4.25 (t, 2H, J ¼ 5.5 Hz), 3.82
(m, 2H), 3.72 (s, 6H), 3.71 (d, 1H, J ¼ 7.0 Hz), 3.63 (dd,
1H, J ¼ 4.3, 10.8 Hz), 3.27 (dd, 1H, J ¼ 1.9, 10.5 Hz),
3.16 (dd, 1H, J ¼ 4.9, 10.5 Hz), 2.71 (m, 1H), 2.32–2.21
(m, 2H), 2.13 (m, 1H), 1.51 (s, 3H), 0.89 (s, 9H), 0.86 (s,
9H), 0.78 (s, 9H), 0.10 (s, 6H), 0.03 (s, 6H), 0.00 (s, 3H),
 0.05 (s, 3H);
13C NMR (125 MHz, (CD3)2SO): d 162.59,
159.98, 159.61, 158.18, 154.04, 150.24, 144.48, 137.37,
135.26, 135.15, 134.41, 129.68, 129.64, 127.84, 127.62,
126.79, 113.89, 113.20, 108.58, 86.95, 85.94, 85.30, 84.81,
82.31, 72.20, 71.24, 62.73, 62.28, 59.68, 55.01, 39.43,
39.33, 38.68, 25.72, 25.64, 25.54, 20.70, 17.91, 17.66,
17.53, 14.03, 12.41,  4.82,  4.99,  5.17,  05.53,  5.57;
ESI MS (M + Na
+): 1202.6 (calcd 1203.6).
1-[O
6-(20-deoxyguanosinyl)]-2-(N
3-thymidinyl)ethane (18).
At room temperature, tetrabutylammonium ﬂuoride (48 mg,
0.15 mmol) was added to a solution of 1-{O
6-[30,50-
O-(bis(tert-butyldimethylsilyl))-20-deoxyguanosinyl]}-2-{N
3-
[50-O-(dimethoxytrityl)-30-O-(tert-butyldimethylsilyl)-thymi-
dinyl]}ethane 17 (36 mg, 0.03 mmol) in THF (1 mL). The
reaction mixture was left at room temperature for 2 h. After
evaporation of the solvent and puriﬁcation by silica gel col-
umn chromatography (EtOAc:MeOH 15:1) the product was
dissolved in MeOH (320 ml) and water (80 ml) followed by
acetic acid (1.6 ml). The reaction mixture was left at room
4460 Nucleic Acids Research, 2006, Vol. 34, No. 16temperature for 3 h and the solvent was then evaporated. The
crude product was dissolved in H2O, washed with EtOAc (3 ·
2 ml). Evaporation of the water gave 18 (14 mg, 85%) as a
white foam. Rf (CH2Cl2/MeOH 5:1) 0.40;
1H NMR
(300 MHz, (CD3)2SO): d 8.06 (s, 1H), 7.77 (s, 1H), 6.34
(br s, 2H), 6.19 (dd, 1H, J ¼ 6.2, 7.6 Hz), 6.16 (t, 1H, J ¼
7.0 Hz), 5.26 (br s, OH, J ¼ 3.8 Hz), 5.23 (br s, OH), 5.00
(br s, OH), 4.99 (t, OH, J ¼ 4.9 Hz), 4.61 (m, 1H), 4.55
(m, 1H), 4.35 (m, 1H), 4.29 (dd, 1H, J ¼ 5.5, 13 Hz), 4.25
(dd, 1H, J ¼ 5.4, 11 Hz), 4.22 (m, 1H), 3.82 (m, 1H), 3.76
(m, 1H), 3.59 (m, 1H), 3.55 (m, 2H), 3.50 (m, 1H), 2.58
(m, 1H), 2.20 (m, 1H), 2.1–2.0 (m, 2H), 1.80 (s, 3H);
13C NMR (75 MHz, (CD3)2SO): d 162.65, 159.99, 159.50,
153.91, 150.43, 137.73, 134.89, 113.91, 108.41, 87.58,
87.37, 84.79, 82.74, 70.74, 70.21, 62.31, 61.72, 61.16,
39.55, 39.47, 39.34, 12.87; ESI MS (M + Na
+): 558.2
(calcd 558.5).
Oligonucleotides synthesis and purification
All oligonuceotides were synthesized on a PerSpective Bio-
systems Expedite 8909 DNA synthesizer on a 1 mmol scale
using the standard ultra-mild protocol. Ultra-mild phosphor-
amidites and Q support were purchased from Glen Research.
6-carboxy ﬂuorescein (6-FAM) phosphoramidite was pur-
chased from Biosearch Technologies. All phosphoramidites
were dissolved to a concentration of 0.1 M in anhydrous
CH3CN. Phenoxyacetic anhydride (0.25 M) in THF was
used as a capping reagent. For the modiﬁed phosphoramidite
the coupling time was extended to 15 min. The coupling yield
of the modiﬁed phosphoramidite was >97%. The oligonuc-
leotide 5 was removed from the solid support and deprotected
by treatment with diisopropylamine/MeOH (1:10) for 17 h at
room temperature, and puriﬁed by reverse phase HPLC using
the following gradient: linear 0–10% B over 10 min, linear
10–20% B until 22 min, linear 20–25% B until 29 min, linear
25–35% B until 33 min, isocratic 100% B until 39 min, iso-
cratic 0% B until 45 min; buffer A: 0.1 M TEAA (pH 7); and
buffer B: CH3CN. The peak of the oligonucleotide 5 eluted
between 20.8 and 21.3 min. Nano-ESI MS: 5366.2 (calcd
5367.0).
Synthesis of cross-linked DNA
Oligonucleotide 5 (60 mM) was mixed with oligonucleotide 6
(12 mM) in 100 mM Hepes (pH 6.3), 300 mM NaCl, and 8 mM
NaI. The mixture was left at room temperature in the dark for
12 days, and the cross-linked product was puriﬁed by JASCO
HPLC using the following gradient: linear 0–20% B over 22
min, linear 20–25% B until 29 min, linear 25–35% B until
33 min, isocratic 100% B until 39 min, isocratic 0% B until
45 min; buffer A: 0.1 M TEAA (pH 7); and buffer B:
CH3CN. The peak of the cross-linked DNA eluted between
28 and 29.5 min. Nano-ESI MS: 10957.0 (calcd 10957.4).
Enzymatic digestion of cross-linked DNA
Interstrand cross-linked DNA (4 nmol) was incubated for
17 h at 30 C with 10 ml of snake venom phosphodiesterase
(1 U) and exonuclease III (5 ml, 500 U) in a buffered solution
containing 50 mM Tris–HCl, 25 mM MgCl2, 1 mM CaCl2,
96 mM NaCl at pH 8. The ﬁnal volume was adjusted to
50 ml. The reaction mixture was then incubated for 10 min
at 30 C with 0.5 ml (5 U) of calf intestine alkaline phos-
phatase (CIP), diluted with H2O (150 ml) and directly injected
into the HPLC using the following gradient: linear 0–10% B
over 25 min, linear 10–35% B until 40 min, isocratic 100% B
until 45 min, isocratic 0% B until 50 min; buffer A: 0.1 M
TEAA (pH 7); and buffer B: CH3CN. The resulting peaks
were identiﬁed by co-injection with the corresponding
standards and eluted at the following times: dC (6.1 min),
dG (13.0 min), T (14.3 min), dA (20.2 min), 14 (35.6 min),
cross-link dimer 18 (37.2 min), 6-FAM (41.7 min).
RESULTS AND DISCUSSION
Design of a sequence-specific alkylation reaction for the
generation of DNA interstrand crosslinks
We set out to design a strategy that would allow for the
incorporation of a precursor of an ethylene-bridged ICL
into one strand of DNA using solid phase synthesis and spe-
ciﬁc alkylation reaction to a complementary strand following
annealing. In our design we ﬁrst considered the reaction of
the CENUs with DNA itself. CENUs initially react with the
oxygen of guanine base to form O
6-chloroethylguanine,
which then undergoes intramolecular cyclization to give
rise to N
1,O
6-ethanoguanine (Figure 1A). This positively
charged intermediate is highly reactive and can undergo nuc-
leophilic attack by the N-3 of cytosine located on the opposite
strand of DNA (14). We reasoned that although the O
6-
chloroethylguanine or N
1,O
6-ethanoguanine intermediates
would likely be too unstable to be incorporated into DNA
by solid phase synthesis (31), it might be possible to mimic
this process in an alkylation reaction with a different reactive
precursor in one strand. In a related study at the (mono) nuc-
leoside level, Miller and coworkers synthesized a thymidine
dimer crosslinked at their N-3 positions through an ethylene
bridge using a 3-iodoethylthymidine derivative as a pre-
cursor, which they subsequently introduced into DNA as a
dimer (20).
We reasoned that it might be possible to use a similar
reaction in the context of dsDNA. Preliminary studies using
1-(2-chloroethyl)-guanosine and 3-(2-chloroethyl)-cytosine
(Figure 1B) revealed that these molecules undergo rapid
cyclization to the N
1,N
2-ethanoguanine and N
3,N
4-ethano-
cytosine, respectively, and would be unsuitable precursors
for a C-G crosslink. In contrast, it appeared that the corres-
ponding 3-(2-chloroethyl)thymidine would be a suitable ICL
precursor with a stability proﬁle that might allow its incorpora-
tion into DNA using solid phase synthesis (see below). We
therefore set out to incorporate 3-(2-chloroethyl)thymidine
into DNA and test its ability to mediate site-speciﬁc ICL
formation.
Preparation of N-3-chloroethylthymidine and its
incorporation into DNA
The synthesis of phosphoramidite 4 containing the chloro-
ethyl thymidine moiety was accomplished as shown in
Figure 2. Alkylation of 50-O-dimethoxytrityl-30-O-tert-
butyldimethylsilylthymidine 1 (28) at N-3 position using
Cs2CO3 and bromochloroethane gave N-3-chloroethyl
product 2 (32). The silyl group was removed from 2 using
Nucleic Acids Research, 2006, Vol. 34, No. 16 4461tetrabutylammonium ﬂuoride to give alcohol 3, which was
converted to the phosphoramidite 4. The building block 4
was thus obtained in a straightforward manner in 68% overall
yield from 1.
Since we were concerned whether the chloroethyl group
would be stable toward base induced hydrolysis, we tested
its stability toward very mild basic deprotection conditions
that we had previously developed (33). Chloroethyl 3 proved
to be stable toward hydrolysis upon extended treatment
in diisopropylamine/methanol (1:10) (data not shown). We
therefore proceeded to incorporate phosphoramidite 4 into
oligonucleotides using ‘ultramild’ phosphoramidites (iPrPac-
dG, Pac-dA and Ac-dC) and Q support (34) and subsequently
removed the oligonucleotide from solid support and removed
base and phosphodiester bond-protecting groups by treatment
with a 10% solution of diisopropylamine in methanol at
room temperature for 17 h. The main product was puriﬁed
by HPLC and analyzed by nano-ESI to conﬁrm its identity
and purity. The observed molecular weight (5366.2) was
indeed consistent with the calculated molecular weight
(5367.0) for oligonucleotide 5.
Site-specific ICL formation
With the chloroethyl thymine-containing oligonucleotide 5 in
hand, we tested its ability to form interstrand crosslinks with
complementary oligonucleotides. We annealed 5 to a comple-
mentary oligonucleotide 6 containing a 6-carboxyﬂuorescein
(6-FAM) at the 50-end and a G opposite to the reactive group.
Following incubation of the two oligonucleotides at room
temperature, we observed the formation of a band with
slower migration in a 20% denaturing PAGE gel, indicative
of ICL formation. The band increased over the course of
2 weeks, eventually yielding  20% of the FAM-labeled oli-
gonucleotide in crosslinked form (Figure 3B, lanes 2–4). The
reaction was of similar efﬁciency in a variety of buffers
(ammonium acetate, sodium acetate, Hepes·KOH, Tris–HCl,
ammonium chloride) and over a wide pH range (5–12) (data
not shown). We carried out our studies in Hepes·KOH at pH
6, which appeared to afford the cleanest reaction. Although
chloride 5 was stable in aqueous solution at room temperature
for several days, after 15 days we observed an increasing
amount of the corresponding alcohol by mass spectrometry
(data not shown). We then studied the inﬂuence of the con-
centrations of oligonucleotides 5 and 6 on the efﬁciency of
the cross-linking reaction. We observed an increase in reac-
tion efﬁciency up to about ﬁve equivalents of oligoncleotide
5 over 6 (Figure 3B, lanes 5–9). Under these conditions, we
consistently achieved a cross-linking yield of 25–30% based
on the unmodiﬁed strand (Figures 3B and 4). We then com-
pared the ability of 5 to react with the four DNA bases. Oli-
gonucleotide 5 exhibited the highest yield of crosslink
formation if paired with guanine with the reactivity decreas-
ing in the order G   A > C   T (Figure 3B, lanes 10–13).
Characterization of cross-linked oligonucleotide 10
The main crosslinked product between oligonucleotides 5 and
6 was puriﬁed by HPLC (Figure 4B) and its mass determined
by nano-ESI-MS. The observed molecular weight (10957.0)
was found to be consistent with the calculated mass
(10957.4) of the cross-linked product. Since two products
of identical mass can be formed by reaction of the chloride
in 5 with either the N-1 or O-6 position of the guanine base
(Figure 1C), we wished to determine the structure of the
Figure 1. Formation of CENU and CENU-like interstrand crosslinks. (A) Mechanism of ICL formation by CENUs. (B) Reactive G, C and T derivatives
considered as cross-linking precursors in this study (C) Cross-linking reaction using 3-(2-chloroethyl)thymidine moiety in DNA may proceed through the O-6 or
N-1 site of guanine.
Figure 2. Synthesis of oligonucleotides containing N-3-
chloroethylthymidine. Reagents and conditions: (a) Cs2CO3, BrCH2CH2Cl,
DMF, 86%. (b) TBAF, THF, 89%. (c) ClP(N(iPr)2)(OEC), (iPr)2NEt,
CH2Cl2, 90%. (d) Solid-phase DNA synthesis and deprotection.
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of the digested product with an authentic standard. We there-
fore needed to synthesize the cross-linked dimers 14 and
18, containing dG alkylated at N-1 and O-6, respectively
(Figure 5). Initial attempts to alkylate the N-1 position of
the protected-20-deoxyguanosine 12 (32) with chloroethyl
compound 2 using different alkylating conditions were not
successful and only the starting materials were isolated. We
reasoned that improving the reactivity of the alkylating
agent might lead to success and replaced the chloride in
2 with iodide, using NaI in acetonitrile. Silver(I) promoted
the alkylation of iodide 11 to yield the fully protected
dimer 13. By contrast, the use of basic conditions (Cs2CO3
or DPU in organic solvents) did not lead to alkylation and
only yielded the corresponding alcohol 15. The fully depro-
tected N1-linked dimer 14 was obtained by consecutive
desilylation using tetrabutylammonium ﬂuoride, deprotection
of the exocyclic amine using NH4OH, and removal of the
trityl group using 80% acetic acid.
The fully protected O6-linked dimer 17 was obtained by
reaction of hydroxyethyl thymine 15, obtained by basic
hydrolysis of iodide 11, and protected 6-chloropurine 16
(29,30) in DME using NaH as a base (Figure 5). Other
attempts, using DMF as a solvent gave a complex mixture
of products, whereas a Mitsunobu reaction between
hydroxyethyl 15 and 30,50-O-(bis(tert-butyldimethylsilyl))-
20-deoxyguanosine yielded no detectable product. The fully
deprotected O6-linked dimer 18 was obtained by desilylation
followed by acid hydrolysis of the trityl group.
Although the two dimers 14 and 18 have identical signals
for their molecular weight ions in MS analysis, they can be
distinguished by
13C-NMR spectroscopy based on their
signals for the methylene groups. The
13C-NMR spectrum
of dimer 14 shows signals at 61.66 and 60.92 p.p.m., corres-
ponding to the two O-CH2 groups of the C-50 deoxyriboses,
and signals at 39.62, 39.43, 38.38, 38.28 p.p.m., correspond-
ing to N-CH2CH2-N and C-20 of the two deoxyribose resi-
dues, respectively. The
13C-NMR spectrum of compound
18 showed signals at 62.31, 61.72, 61.16 p.p.m., indicating
the presence of three O-CH2 groups: two for C-50 of the deox-
yriboses, and one for the O-ethylene bridge; the other three
signals, at 39.55, 39.47, 33.34 p.p.m., correspond to N-CH2
and the C-20 of the two deoxyribose moieties.
The availability of the authentic standards 14 and 18
allowed us to identify the structure of the ICL in oligo-
nucleotide 10. Cross-link oligonucleotide 10 was enzymatic-
ally digested, dephosphorylated and analyzed by HPLC
(Figure 6B). In addition to the four natural nucleosides dC,
dG, T and dA, we observed two additional peaks; the ﬁrst
one corresponded to the ﬂuorescent label at the 50 end of
the G containing oligonucleotide. The second one co-eluted
with the O6-linked dimer 18 with a retention time of 37.2
minutes, clearly distinct from 14, which eluted at 35.6 min.
The nucleoside composition analysis therefore establishes
that the crosslink is formed exclusively between N-3 of T
and O-6 of dG.
Mechanism of ICL formation between N-3 of T and
O-6 of G
The exclusive reaction of the chloroethyl group of T with
O-6 of dG and absence of reaction with N-1 of dG deserves
some comment. It appears that the chlorine in 3-(2-
chloroethyl)thymidine is very inert due to the two electron-
withdrawing groups in the pyrimidine ring, rendering it unre-
active toward direct substitution by oxygen or nitrogen nuc-
leophiles. This is illustrated by the extremely low reactivity
of 2 toward nucleophilic substitution under aprotic conditions
(Figure 5). Likewise, a direct SN2 substitution of the chloride
in the context of dsDNA is not a likely event. However, under
solvolytic conditions, the formation of the ionic intermediate
19 (Figure 7) may occur at low frequency due to the intra-
molecular nature of this cyclization reaction. The ionic char-
acter of 19 causes it to react exclusively with the oxygen of
the amide bond in dG, due to the latter’s partial anionic char-
acter. This mechanism accounts for the very slow ICL forma-
tion, because the frequency of the formation of 19 is very
low. Once it is formed it is likely to react very quickly
with the closest nucleophile with anionic character, in this
case O-6 of dG.
This preferential reactivity of oxygen-centered rather than
nitrogen-centered nucleophiles with electrophiles with ionic
Figure 4. HPLC analysis of T-G interstrand crosslinks. (A) HPLC profile of
the oligonucleotides 5 and 6 before the cross-linking reaction. (B) HPLC
profile of formation of ICL 10 after incubation of 5 and 6 for 12 days at room
temperature.
Figure 3. (A) Schematic representation of the cross-linking reaction; 3-(2-
chloroethyl)-T containing oligonucleotide 5 was annealed to complementary
fluorescently labeled oligonucleotides 6–9 (6:N¼ G; 7:N¼ A; 8:N¼ C; 9:
N ¼ T; F ¼ 6-carboxy fluorescein, 6-FAM) and ICL formation was analyzed
by 20% denaturing PAGE. (B) Analysis of ICL formation by 20% denaturing
PAGE. The oligonucleotides used, incubation times, and yields are indicated
above the gel. The following concentrations of substrates were used:
oligonucleotide 5: lanes 1–4, 36 mM; lane 5, 12 mM; lane 6, 24 mM;
7, 10–13, 60 mM; lane 8, 84 mM; lane 9, 108 mM; oligonucleotides
6–9: 12mM.
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with the DNA bases. Alkylating agents such as N-methyl-N-
nitrosourea (NMU), which react with an SN1-like mechanism
with cationic character in the transition state, are highly oxo-
philic and show high reactivity with O-6 of dG (35,36). Less
reactive alkylating agents that react by an SN2-type mechan-
isms without signiﬁcant positive charge in the transition state
instead prefer to react with nitrogen-based nucleophile in
DNA such as N-7 of G.
Our results suggest that the development of a related strat-
egy for the preparation of the (N-1)G–(N-3)C crosslink,
formed by various CENUs would likely have to rely on a pre-
cursor that allows the in situ formation of the charged N
1,O
6-
ethanoguanosine intermediate. In this case, where a C base is
situated to act as a nucleophile to react with the ethano-
guanosine cation, the N-3 of C, which contains more anionic
character than N-4, is known to react as the nucleophile
(14,27). In the interim the G-T crosslink generated here
will serve as a useful mimic for the study of ethylene-bridged
ICLs for the investigation of the repair pathways for this type
of lesion.
CONCLUSIONS
We have developed a simple and concise approach for the
synthesis of an ethylene bridged DNA interstrand crosslink.
For this purpose we have synthesized an oligonucleotide
carrying a chloroethyl moiety at a deﬁned T base poised to
Figure 6. Enzymatic digesion analysis of an oligonucleotide containing a
G-T ICL. (A) HPLC profile of oligonucleotide 6 following enzymatic
digestion and dephosphporylation. The four nucleosides and fluorescent label
6-FAM are indicated. (B) HPLC profile of ICL-containing oligonucleotide 10
after enzymatic digestion and dephosphorylation. The peak for the cross-
linked T-G residue is denoted by an arrow (C) HPLC profiles of the T(N3)-
dG(N1) dimer 14 and the T(N3)-dG(O6) dimer 18.
Figure 5. Synthesis of crosslinked dimers 14 and 18. Reagents and conditions: a) NaI, CH3CN, 70 , 86%. b) Ag2O, DMF, 48%. c) i) TBAF, THF. ii) NH4OH. iii)
80% CH3COOH, 32%. d) NaOH, THF, 71%. e) NaH, DME, 74%. f) i) TBAF, THF. ii) 80% CH3COOH, 85%.
Figure 7. Proposed mechanism for the formation of the (O6)G-(N3)T
crosslink. An intramolecular substitution of the chloride in 5 leads to
the positively charged N
3,O
4-ethanothymidine (19). Equivalent formation
of O
2,N
3-ethanothymidine might also occur. 19 reacts exclusively with
O-6 of the opposite guanine base due to more anionic character of O-6 versus
N-1 of G.
4464 Nucleic Acids Research, 2006, Vol. 34, No. 16react selectively with a base on a complementary DNA
strand. To our knowledge this constitutes the ﬁrst example
of an oligonucleotide with an alkyl chloride side chain and
one of a few examples of a speciﬁc ICL formation using a
reactive group on one strand of DNA (21–23). Since
oligonucleotides containing 2-chloroethylthymidine have in
principle the ability to react with different types of DNA in
a sequence-speciﬁc manner, they might also be generally
useful for the sequence-speciﬁc covalent modiﬁcation of
DNA. Given the slow kinetics of the cross-linking reaction,
it remains to be seen whether it will be useful in the
context of gene-modiﬁcation using antisense or triple-helix
approaches (37–39).
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